<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5.1//EN" "ep-patent-document-v1-5-1.dtd">
<!-- This XML data has been generated under the supervision of the European Patent Office -->
<ep-patent-document id="EP17190771B1" file="EP17190771NWB1.xml" lang="en" country="EP" doc-number="3382002" kind="B1" date-publ="20210804" status="n" dtd-version="ep-patent-document-v1-5-1">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................</B001EP><B005EP>J</B005EP><B007EP>BDM Ver 1.7.2 (20 November 2019) -  2100000/0</B007EP></eptags></B000><B100><B110>3382002</B110><B120><B121>EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B1</B130><B140><date>20210804</date></B140><B190>EP</B190></B100><B200><B210>17190771.0</B210><B220><date>20170913</date></B220><B240><B241><date>20190328</date></B241><B242><date>20190611</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>106111144</B310><B320><date>20170331</date></B320><B330><ctry>TW</ctry></B330></B300><B400><B405><date>20210804</date><bnum>202131</bnum></B405><B430><date>20181003</date><bnum>201840</bnum></B430><B450><date>20210804</date><bnum>202131</bnum></B450><B452EP><date>20210217</date></B452EP></B400><B500><B510EP><classification-ipcr sequence="1"><text>C11D   3/00        20060101AFI20180814BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>C11D   3/37        20060101ALI20180814BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>C11D   1/04        20060101ALI20180814BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>C11D   1/24        20060101ALI20180814BHEP        </text></classification-ipcr><classification-ipcr sequence="5"><text>C11D   1/29        20060101ALI20180814BHEP        </text></classification-ipcr><classification-ipcr sequence="6"><text>C11D   1/72        20060101ALI20180814BHEP        </text></classification-ipcr><classification-ipcr sequence="7"><text>C11D   1/14        20060101ALI20180814BHEP        </text></classification-ipcr><classification-ipcr sequence="8"><text>C11D   1/34        20060101ALI20180814BHEP        </text></classification-ipcr><classification-ipcr sequence="9"><text>C11D   1/66        20060101ALI20180814BHEP        </text></classification-ipcr><classification-ipcr sequence="10"><text>C11D   3/20        20060101ALI20180814BHEP        </text></classification-ipcr><classification-ipcr sequence="11"><text>C11D   3/18        20060101ALI20180814BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>ZUSAMMENSETZUNG FÜR KONTAKTLINSE</B542><B541>en</B541><B542>COMPOSITION FOR CONTACT LENS</B542><B541>fr</B541><B542>COMPOSITION POUR LENTILLE DE CONTACT</B542></B540><B560><B561><text>WO-A1-96/03158</text></B561><B561><text>US-A1- 2008 095 754</text></B561><B561><text>US-A1- 2017 056 335</text></B561><B561><text>US-A1- 2017 087 199</text></B561><B561><text>US-B1- 6 228 323</text></B561><B562><text>Anonymous: "Algefacient | definition of algefacient by Medical dictionary", Medical dictionary, 6 April 2018 (2018-04-06), pages 1-2, XP055465196, Retrieved from the Internet: URL:https://medical-dictionary.thefreedict ionary.com/algefacient [retrieved on 2018-04-06]</text></B562></B560></B500><B700><B720><B721><snm>CHANG, Han-Yi</snm><adr><str>2F., No. 37, Minsheng Street
Zhonghe District</str><city>New Taipei City 235</city><ctry>TW</ctry></adr></B721><B721><snm>CHEN, Li-Ju</snm><adr><str>2F., No. 3, Aly. 3, Ln. 91, Sec. 4, Bade Road
Songshan District</str><city>Taipei City 105</city><ctry>TW</ctry></adr></B721></B720><B730><B731><snm>Pegavision Corporation</snm><iid>101563052</iid><irf>P68775</irf><adr><str>2F-1, No. 5, Shing Yeh Street 
Guishan District</str><city>Taoyuan City 333</city><ctry>TW</ctry></adr></B731></B730><B740><B741><snm>Viering, Jentschura &amp; Partner mbB 
Patent- und Rechtsanwälte</snm><iid>101239391</iid><adr><str>Hamborner Straße 53</str><city>40472 Düsseldorf</city><ctry>DE</ctry></adr></B741></B740></B700><B800><B840><ctry>AL</ctry><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>RS</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>SM</ctry><ctry>TR</ctry></B840></B800></SDOBI>
<description id="desc" lang="en"><!-- EPO <DP n="1"> -->
<heading id="h0001">BACKGROUND OF THE INVENTION</heading>
<heading id="h0002">1. Field of the Invention</heading>
<p id="p0001" num="0001">The instant disclosure relates to a composition for contact lenses; in particular, to a composition for contact lenses which can serve as a contact lens preservation solution.</p>
<heading id="h0003">2. Description of Related Art</heading>
<p id="p0002" num="0002">Smartphones and computers are used frequently in today's information society, resulting in an increase in the population with myopia and a decrease in the age group of myopia. In consideration of user convenience and aesthetics, it is generally a good choice for people with myopia to wear contact lenses. However, most people with myopia need to wear contact lenses for extended periods of time. Although the material of the conventional contact lenses have been constantly improved to meet various requirements such as high water content and high oxygen permeability, the wearers thereof would still suffer from eye dryness due to decreased water content and experience eye discomfort due to dirt or secretion. Therefore, there is an urgent need for a maintenance solution that can be used to clean, rehydrate and preserve contact lenses. <patcit id="pcit0001" dnum="US2017056335A1"><text>US2017056335 A1</text></patcit> discloses an ophthalmic composition comprising polysorbate 80 and a refreshing agent. <patcit id="pcit0002" dnum="WO9603158A1"><text>WO9603158 A1</text></patcit> and <patcit id="pcit0003" dnum="US6228323B1"><text>US 6 228 323 B1</text></patcit> disclose compositions for contact lenses which include sodium lauroyl lactylate.</p>
<heading id="h0004">SUMMARY OF THE INVENTION</heading>
<p id="p0003" num="0003">One aspect of the instant disclosure relates to a composition for contact lens which allows a contact lens wearer's eyes to feel comfortable during the period of initial wear and extended periods of continuous wear.<!-- EPO <DP n="2"> --></p>
<p id="p0004" num="0004">According to one of the embodiments of the instant disclosure, the composition for contact lenses includes an algefacient and a surfactant, and a water soluble polymer, wherein the surfactant is sodium lauroyl lactylate, wherein the algefacient includes one or a combination of menthol, camphor, borneol, menthyl lactate, menthone glycerol ketal, monomethyl succinate, and p-menthane-3,8-diol; and wherein the water soluble polymer includes PEG 400 and MPC in a molar ratio of 1:20.</p>
<p id="p0005" num="0005">Based on the above, by cooperatively using the algefacient and the surfactant, wherein the surfactant is sodium lauroyl lactylate and the expression of the algefacient in the composition of a contact lens can be performed effectively. Therefore, the discomfort and foreign matter sensation in the eyes of contact lens wearers can be reduced or relieved, providing long-lasting cool and moist sensations to the eyes.</p>
<p id="p0006" num="0006">In order to further appreciate the characteristics and technical contents of the instant disclosure, references are hereunder made to the detailed descriptions and appended drawings in connection with the instant disclosure. However, the appended drawings are merely shown for exemplary purposes, rather than being used to restrict the scope of the instant disclosure.</p>
<heading id="h0005">BRIEF DESCRIPTION OF THE DRAWINGS</heading>
<p id="p0007" num="0007"><figref idref="f0001">Fig. 1</figref> is a perspective view showing a contact lens and a composition for contact lenses according to the instant disclosure in a container.<!-- EPO <DP n="3"> --></p>
<heading id="h0006">DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS</heading>
<p id="p0008" num="0008">The aforementioned illustrations and following detailed descriptions are exemplary for the purpose of further explaining the scope of the instant disclosure. Other objectives and advantages related to the instant disclosure will be illustrated in the subsequent descriptions and appended drawings.</p>
<p id="p0009" num="0009">Referring to <figref idref="f0001">FIG. 1</figref>, the instant disclosure provides a composition for contact lenses which can serve as a preservation solution and be hermetically sealed with the contact lenses in a container. In practice, the contact lenses are immersed in direct contact with the composition. When the user wishes to wear the contact lenses, the user takes the contact lens out of the composition and put the contact lenses on his/her eyes. More specifically, the ingredients of the composition absorb onto the surface of the contact lenses and then transfer into the user's eyes.</p>
<p id="p0010" num="0010">The composition according to the instant embodiment is intended for use in connection with soft and rigid contact lenses. The term "soft contact lens" can refer to a hydrous soft contact lens made from hydrogels (i.e., hydrogel contact lenses) and a non-hydrous soft contact lens made from copolymers of butyl acrylate and butyl methacrylate. Furthermore, the composition according to the instant embodiment is applicable to the soft contact lenses in U.S. FDA category Group I-IV. Group I-IV lenses often contain materials identified in the market as: alphafilcon, asmofilcon, balafilcon, ethafilcon, hefilcon, hilafilcon, lidofilcon, lotrafilcon, methafilcon, nelfilcon, ocufilcon, omafilcon, phemfilcon, polymacon, tefilcon, tetrafilcon,<!-- EPO <DP n="4"> --> vasurfilcon, vifilcon, senofilcon, galyfilcon, enfilcon, comfilcon, narafilcon, delefilcon, efrofilcon, and filicon II 3.</p>
<p id="p0011" num="0011">The composition according to the instant embodiment mainly includes a base solution, an algefacient, a surfactant, and a water soluble polymer. The algefacient, the surfactant, and the water soluble polymer are uniformly dispersed in the base solution.</p>
<p id="p0012" num="0012">In the instant embodiment, the base solution is a physiological saline solution with a buffer containing boric acid or phosphorous acid. The buffer has a pH buffering capacity and is configured to adjust the pH of the composition to a pH between 6.8 and 7.6. In addition, the base solution can include an appropriate amount of sodium chloride or potassium chloride to maintain the osmolality of the composition at a value between 250 Osmol/Kg and 350 Osmol/Kg.</p>
<p id="p0013" num="0013">The buffer can be selected from boric acid, borate (e.g., sodium tetraborate), phosphorous acid, or phosphate (e.g., sodium hydrogen phosphate and sodium dihydrogen phosphate). It should be noted that a buffer may be used alone or two or more different buffers may be used in combination in the base solution. In addition, the concentration of the buffer may be appropriately adjusted depending on its kind or the kind of the other ingredients.</p>
<p id="p0014" num="0014">The algefacient is added to reduce or relieve the discomfort and foreign matter sensation in the eyes and give the eyes a cool, fresh sensation. The algefacient includes one or a combination of menthol, camphor, borneol, menthyl lactate, menthone glycerol ketal, monomethyl succinate, and p-menthane-3,8-diol. The content of the algefacient is in the range between<!-- EPO <DP n="5"> --> 0.001% (w/v) and 0.5 % (w/v), preferably between 0.001% (w/v) and 0.25 % (w/v), to avoid irritating the eye.</p>
<p id="p0015" num="0015">The surfactant is added to clean and moisturize a contact lens, in which protein and lipid deposits on the surfaces of the contact lens can be removed. The surfactant is sodium lauroyl lactylate. The content of the surfactant is in the range between 0.001% (w/v) and 2% (w/v), and preferably between 0.001% (w/v) and 0.5 % (w/v).</p>
<p id="p0016" num="0016">It should be noted that by cooperatively using the algefacient and the surfactant, the expression of the algefacient in the composition for contact lenses can be performed effectively. Therefore, eye related symptoms such as eye fatigue, eye dryness, eye pruritus, and eye pain can be reduced or relieved, and a cool fresh sensation in the eyes can be maintained for a long period of time.</p>
<p id="p0017" num="0017">The water soluble polymer is added to moisten and lubricate the eyes, and also helps to keep the ingredients beneficial to the eyes in contact with the contact lens. For example, if the composition for contact lenses includes one or more vitamins (e.g., A, B and E), the vitamin(s) can be attached to the surface of the contact lens by interacting with the water soluble polymer. The water soluble polymer includes PEG 400 and<!-- EPO <DP n="6"> --> MPC in a molar ratio of 1:20. The content of the water soluble polymer is in the range between 0.05% (w/v) and 5% (w/v).</p>
<p id="p0018" num="0018">Comparative Examples 1-5 and Comparative Examples 1-2 are shown in Table 1. Each of the compositions obtained respectively in Comparative Examples 1-5 and Comparative Examples 1-2 was used in full contact with the contact lenses. The contact lenses were then put on the user's eyes, and a VAS (Visual analogue scale) method was used to evaluate the sensations of lubrication, comfort, coolness, and moisture in the eyes during the period of initial wear (time 1) and after wearing for 30 minutes (time 2) and 60 minutes (time 3). The evaluation results of for the Comparative Examples 1-5 and the Comparative Examples 1-2 are shown in Table 2. Scores for each of the items, as shown in Table 2, are average scores calculated from three users (i.e., six eyes).
<tables id="tabl0001" num="0001">
<table frame="all">
<title>Table 1</title>
<tgroup cols="8">
<colspec colnum="1" colname="col1" colwidth="55mm"/>
<colspec colnum="2" colname="col2" colwidth="16mm"/>
<colspec colnum="3" colname="col3" colwidth="16mm"/>
<colspec colnum="4" colname="col4" colwidth="16mm"/>
<colspec colnum="5" colname="col5" colwidth="17mm"/>
<colspec colnum="6" colname="col6" colwidth="17mm"/>
<colspec colnum="7" colname="col7" colwidth="16mm"/>
<colspec colnum="8" colname="col8" colwidth="16mm"/>
<thead>
<row>
<entry morerows="2" align="center" valign="middle"/>
<entry namest="col2" nameend="col8" align="right" valign="middle">unit: g</entry></row>
<row>
<entry namest="col2" nameend="col6" align="center" valign="middle">Examples</entry>
<entry namest="col7" nameend="col8" align="center" valign="middle">Comparative ex</entry></row>
<row>
<entry align="center" valign="middle">1</entry>
<entry align="center" valign="middle">2</entry>
<entry align="center" valign="middle">3</entry>
<entry align="center" valign="middle">4</entry>
<entry align="center" valign="middle">5</entry>
<entry align="center" valign="middle">1</entry>
<entry align="center" valign="middle">2</entry></row></thead>
<tbody>
<row>
<entry align="center" valign="middle">water</entry>
<entry align="center" valign="middle">2000</entry>
<entry align="center" valign="middle">2000</entry>
<entry align="center" valign="middle">2000</entry>
<entry align="center" valign="middle">2000</entry>
<entry align="center" valign="middle">2000</entry>
<entry align="center" valign="middle">2000</entry>
<entry align="center" valign="middle">2000</entry></row>
<row>
<entry align="center" valign="middle">sodium chloride</entry>
<entry align="center" valign="middle">10-20</entry>
<entry align="center" valign="middle">10-20</entry>
<entry align="center" valign="middle">10-20</entry>
<entry align="center" valign="middle">10-20</entry>
<entry align="center" valign="middle">10-20</entry>
<entry align="center" valign="middle">10-20</entry>
<entry align="center" valign="middle">10-20</entry></row>
<row>
<entry align="center" valign="middle">boric acid</entry>
<entry align="center" valign="middle">8-16</entry>
<entry align="center" valign="middle">8-16</entry>
<entry align="center" valign="middle">8-16</entry>
<entry align="center" valign="middle">8-16</entry>
<entry align="center" valign="middle">8-16</entry>
<entry align="center" valign="middle">8-16</entry>
<entry align="center" valign="middle">8-16</entry></row>
<row>
<entry align="center" valign="middle">sodium tetraborate</entry>
<entry align="center" valign="middle">0.5-4.5</entry>
<entry align="center" valign="middle">0.5-4.5</entry>
<entry align="center" valign="middle">0.5-4.5</entry>
<entry align="center" valign="middle">0.5-4.5</entry>
<entry align="center" valign="middle">0.5-4.5</entry>
<entry align="center" valign="middle">0.5-4.5</entry>
<entry align="center" valign="middle">0.5-4.5</entry></row>
<row>
<entry align="center" valign="middle">TWEEN 80™</entry>
<entry align="center" valign="middle">0.01-5</entry>
<entry align="center" valign="middle">0.01-5</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">0.01-5</entry>
<entry align="center" valign="middle">0.01-5</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">-</entry></row>
<row>
<entry align="center" valign="middle">PVP</entry>
<entry align="center" valign="middle">0.01-5</entry>
<entry align="center" valign="middle">0.01-5</entry>
<entry align="center" valign="middle">0.01-5</entry>
<entry align="center" valign="middle">0</entry>
<entry align="center" valign="middle">0.01-5</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">-</entry></row>
<row>
<entry align="center" valign="middle">GEROPON™ SBFA-30</entry>
<entry align="center" valign="middle">0</entry>
<entry align="center" valign="middle">0.01-5</entry>
<entry align="center" valign="middle">0.01-5</entry>
<entry align="center" valign="middle">0</entry>
<entry align="center" valign="middle">0.01-5</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">-</entry></row>
<row>
<entry align="center" valign="middle">polyoxyethylene hardened castor oil</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">0.01-2.5</entry>
<entry align="center" valign="middle">0.01-2.5</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">-</entry></row>
<row>
<entry align="center" valign="middle">Hyaluronic acid (HA)</entry>
<entry align="center" valign="middle">0-50</entry>
<entry align="center" valign="middle">0-50</entry>
<entry align="center" valign="middle">0-50</entry>
<entry align="center" valign="middle">0-50</entry>
<entry align="center" valign="middle">0-50</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">0-50</entry></row>
<row>
<entry align="center" valign="middle">PEG400</entry>
<entry align="center" valign="middle">0-50</entry>
<entry align="center" valign="middle">0-50</entry>
<entry align="center" valign="middle">0-50</entry>
<entry align="center" valign="middle">0-50</entry>
<entry align="center" valign="middle">0-50</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">0-50</entry></row>
<row>
<entry align="center" valign="middle">MPC</entry>
<entry align="center" valign="middle">0-50</entry>
<entry align="center" valign="middle">0-50</entry>
<entry align="center" valign="middle">0-50</entry>
<entry align="center" valign="middle">0-50</entry>
<entry align="center" valign="middle">0-50</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">0-50</entry></row>
<row>
<entry align="center" valign="middle">menthol</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">0-4</entry></row>
<row>
<entry align="center" valign="middle">camphor</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">0-4</entry></row>
<row>
<entry align="center" valign="middle">borneol</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">0-4</entry></row><!-- EPO <DP n="7"> -->
<row>
<entry align="center" valign="middle">menthyl lactate</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">0-4</entry></row>
<row>
<entry align="center" valign="middle">menthone-glycerol ketal</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">0-4</entry></row>
<row>
<entry align="center" valign="middle">monomethyl succinate</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">0-4</entry></row>
<row>
<entry align="center" valign="middle">p-menthane-3,8-doil</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">0-4</entry>
<entry align="center" valign="middle">-</entry>
<entry align="center" valign="middle">0-4</entry></row></tbody></tgroup>
</table>
</tables>
<tables id="tabl0002" num="0002">
<table frame="all">
<title>Table 2</title>
<tgroup cols="4">
<colspec colnum="1" colname="col1" colwidth="34mm"/>
<colspec colnum="2" colname="col2" colwidth="35mm"/>
<colspec colnum="3" colname="col3" colwidth="20mm"/>
<colspec colnum="4" colname="col4" colwidth="27mm"/>
<thead>
<row>
<entry morerows="1" align="center" valign="middle">evaluation items</entry>
<entry morerows="1" align="center" valign="middle">wear-in time</entry>
<entry namest="col3" nameend="col4" align="center" valign="middle">self-feeling score</entry></row>
<row>
<entry align="center" valign="middle">Examples</entry>
<entry align="center" valign="middle">Comparative ex</entry></row></thead>
<tbody>
<row>
<entry morerows="2" align="center" valign="middle">lubrication sensation</entry>
<entry align="center" valign="middle">immediately right after</entry>
<entry align="center" valign="middle">7</entry>
<entry align="center" valign="middle">8</entry></row>
<row>
<entry align="center" valign="middle">after 30 minutes</entry>
<entry align="center" valign="middle">7</entry>
<entry align="center" valign="middle">8</entry></row>
<row>
<entry align="center" valign="middle">after 60 minutes</entry>
<entry align="center" valign="middle">6</entry>
<entry align="center" valign="middle">8</entry></row>
<row>
<entry morerows="2" align="center" valign="middle">comfort sensation</entry>
<entry align="center" valign="middle">immediately right after</entry>
<entry align="center" valign="middle">7</entry>
<entry align="center" valign="middle">8</entry></row>
<row>
<entry align="center" valign="middle">after 30 minutes</entry>
<entry align="center" valign="middle">7</entry>
<entry align="center" valign="middle">8</entry></row>
<row>
<entry align="center" valign="middle">after 60 minutes</entry>
<entry align="center" valign="middle">7</entry>
<entry align="center" valign="middle">8</entry></row>
<row>
<entry morerows="2" align="center" valign="middle">coolness sensation</entry>
<entry align="center" valign="middle">immediately right after</entry>
<entry align="center" valign="middle">NA</entry>
<entry align="center" valign="middle">9</entry></row>
<row>
<entry align="center" valign="middle">after 30 minutes</entry>
<entry align="center" valign="middle">NA</entry>
<entry align="center" valign="middle">6</entry></row>
<row>
<entry align="center" valign="middle">after 60 minutes</entry>
<entry align="center" valign="middle">NA</entry>
<entry align="center" valign="middle">4</entry></row>
<row>
<entry morerows="2" align="center" valign="middle">moisture sensation</entry>
<entry align="center" valign="middle">immediately right after</entry>
<entry align="center" valign="middle">8</entry>
<entry align="center" valign="middle">10</entry></row>
<row>
<entry align="center" valign="middle">after 30 minutes</entry>
<entry align="center" valign="middle">8</entry>
<entry align="center" valign="middle">9</entry></row>
<row>
<entry align="center" valign="middle">after 60 minutes</entry>
<entry align="center" valign="middle">8</entry>
<entry align="center" valign="middle">9</entry></row></tbody></tgroup>
</table>
</tables></p>
<p id="p0019" num="0019">The composition for contact lenses in which the algefacient and the surfactant are cooperatively used and the surfactant is sodium lauroyl lactylate. Accordingly, the expression of the algefacient can be performed effectively, so that the discomfort and foreign matter sensation in the eyes of contact lens<!-- EPO <DP n="8"> --> wearers can be reduced or relieved, and long-lasting cool and moist sensations can be provided to the eyes.</p>
</description>
<claims id="claims01" lang="en"><!-- EPO <DP n="9"> -->
<claim id="c-en-01-0001" num="0001">
<claim-text>A composition for contact lenses which includes an algefacient, a surfactant, and a water soluble polymer, wherein the surfactant is sodium lauroyl lactylate, wherein the algefacient includes one or a combination of menthol, camphor, borneol, menthyl lactate, menthone glycerol ketal, monomethyl succinate, and p-menthane-3,8-diol; and wherein the water soluble polymer includes polyethylene glycol 400 (PEG 400) and methacryloyloxyethyl phosphorylcholine (MPC) in a molar ratio of 1:20.</claim-text></claim>
<claim id="c-en-01-0002" num="0002">
<claim-text>The composition for contact lens according to claim 1, wherein the content of the surfactant is in the range between 0.001% (w/v) and 0.5% (w/v).</claim-text></claim>
<claim id="c-en-01-0003" num="0003">
<claim-text>The composition for contact lens according to claim 1, wherein the algefacient is menthol.</claim-text></claim>
<claim id="c-en-01-0004" num="0004">
<claim-text>The composition for contact lens according to claim 1 or 3, wherein the content of the algefacient is in the range between 0.001% (w/v) and 0.25 % (w/v).</claim-text></claim>
<claim id="c-en-01-0005" num="0005">
<claim-text>The composition for contact lens according to claim 1, wherein the content of the water soluble polymer is in the range between 0.05% (w/v) and 5% (w/v).</claim-text></claim>
<claim id="c-en-01-0006" num="0006">
<claim-text>The composition for contact lens according to claim 1, further including a buffer, wherein the buffer includes boric acid and sodium tetraborate.</claim-text></claim>
</claims>
<claims id="claims02" lang="de"><!-- EPO <DP n="10"> -->
<claim id="c-de-01-0001" num="0001">
<claim-text>Zusammensetzung für Kontaktlinsen, die ein Algefaciens, ein Tensid und ein wasserlösliches Polymer enthält, wobei das Tensid Natriumlauroyllactylat ist, wobei das Algefaciens eines oder eine Kombination von Menthol, Kampfer, Borneol, Menthyllactat, Menthonglycerolketal, Monomethylsuccinat und p-Menthan-3,8-diol enthält; und wobei das wasserlösliche Polymer Polyethylenglycol 400 (PEG 400) und Methacryloyloxyethylphosphorylcholin (MPC) in einem molaren Verhältnis von 1:20 enthält.</claim-text></claim>
<claim id="c-de-01-0002" num="0002">
<claim-text>Die Zusammensetzung für Kontaktlinsen gemäß Anspruch 1, wobei der Gehalt an Tensid im Bereich zwischen 0,001% (w/v) und 0,5% (w/v) liegt.</claim-text></claim>
<claim id="c-de-01-0003" num="0003">
<claim-text>Die Zusammensetzung für Kontaktlinsen gemäß Anspruch 1, wobei das Algefaciens Menthol ist.</claim-text></claim>
<claim id="c-de-01-0004" num="0004">
<claim-text>Die Zusammensetzung für Kontaktlinsen gemäß Anspruch 1 oder 3, wobei der Gehalt an Algefaciens im Bereich zwischen 0,001 % (w/v) und 0,25 % (w/v) liegt.</claim-text></claim>
<claim id="c-de-01-0005" num="0005">
<claim-text>Die Zusammensetzung für Kontaktlinsen gemäß Anspruch 1, wobei der Gehalt an wasserlöslichem Polymer im Bereich zwischen 0,05 % (w/v) und 5 % (w/v) liegt.</claim-text></claim>
<claim id="c-de-01-0006" num="0006">
<claim-text>Die Zusammensetzung für Kontaktlinsen gemäß Anspruch 1, des Weiteren enthaltend einen Puffer, wobei der Puffer Borsäure und Natriumtetraborat enthält.</claim-text></claim>
</claims>
<claims id="claims03" lang="fr"><!-- EPO <DP n="11"> -->
<claim id="c-fr-01-0001" num="0001">
<claim-text>Composition pour lentilles de contact qui comprend un agent de rafraîchissement, un tensioactif, et un polymère hydrosoluble, dans laquelle le tensioactif est le lauroyl lactylate de sodium, dans laquelle l'agent rafraîchissant comprend un ou une combinaison du menthol, du camphre, du bornéol, du lactate de menthyle, du glycérol cétal de menthone, du succinate de monométhyle, et du p-menthane-3,8-diol ;<br/>
et dans laquelle le polymère hydrosoluble comprend le polyéthylène glycol 400 (PEG 400) et la méthacryloyloxyéthyl phosphorylcholine (MPC) dans un rapport molaire de 1:20.</claim-text></claim>
<claim id="c-fr-01-0002" num="0002">
<claim-text>Composition pour lentille de contact selon la revendication 1, dans laquelle la teneur du tensioactif se trouve dans la plage entre 0,001 % (m/v) et 0,5 % (m/v).</claim-text></claim>
<claim id="c-fr-01-0003" num="0003">
<claim-text>Composition pour lentille de contact selon la revendication 1, dans laquelle l'agent de rafraîchissement est le menthol.</claim-text></claim>
<claim id="c-fr-01-0004" num="0004">
<claim-text>Composition pour lentille de contact selon la revendication 1 ou 3, dans laquelle la teneur de l'agent de rafraîchissement se trouve dans la plage entre 0,001 % (m/v) et 0,25 % (m/v).</claim-text></claim>
<claim id="c-fr-01-0005" num="0005">
<claim-text>Composition pour lentille de contact selon la revendication 1, dans laquelle la teneur du polymère hydrosoluble se trouve dans la plage entre 0,05 % (m/v) et 5 % (m/v).</claim-text></claim>
<claim id="c-fr-01-0006" num="0006">
<claim-text>Composition pour lentille de contact selon la revendication 1, comprenant en outre un tampon, dans laquelle le tampon comprend l'acide borique et le tétraborate de sodium.</claim-text></claim>
</claims>
<drawings id="draw" lang="en"><!-- EPO <DP n="12"> -->
<figure id="f0001" num="1"><img id="if0001" file="imgf0001.tif" wi="97" he="111" img-content="drawing" img-format="tif"/></figure>
</drawings>
<ep-reference-list id="ref-list">
<heading id="ref-h0001"><b>REFERENCES CITED IN THE DESCRIPTION</b></heading>
<p id="ref-p0001" num=""><i>This list of references cited by the applicant is for the reader's convenience only. It does not form part of the European patent document. Even though great care has been taken in compiling the references, errors or omissions cannot be excluded and the EPO disclaims all liability in this regard.</i></p>
<heading id="ref-h0002"><b>Patent documents cited in the description</b></heading>
<p id="ref-p0002" num="">
<ul id="ref-ul0001" list-style="bullet">
<li><patcit id="ref-pcit0001" dnum="US2017056335A1"><document-id><country>US</country><doc-number>2017056335</doc-number><kind>A1</kind></document-id></patcit><crossref idref="pcit0001">[0002]</crossref></li>
<li><patcit id="ref-pcit0002" dnum="WO9603158A1"><document-id><country>WO</country><doc-number>9603158</doc-number><kind>A1</kind></document-id></patcit><crossref idref="pcit0002">[0002]</crossref></li>
<li><patcit id="ref-pcit0003" dnum="US6228323B1"><document-id><country>US</country><doc-number>6228323</doc-number><kind>B1</kind></document-id></patcit><crossref idref="pcit0003">[0002]</crossref></li>
</ul></p>
</ep-reference-list>
</ep-patent-document>
